Abiraterone in prostate cancer: a new angle to an old problem
about
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancerAbiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born.Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancerCombination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer CellsCorepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.BET bromodomain inhibitors--a novel epigenetic approach in castration-resistant prostate cancer.Minireview: Androgen metabolism in castration-resistant prostate cancer.A hormone-DNA repair circuit governs the response to genotoxic insultAdvances in androgen receptor targeted therapy for prostate cancerCombination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer.Copper signaling axis as a target for prostate cancer therapeutics.Prostate cancer: beware of disseminated intravascular coagulation.Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer.Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis.Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage.Brefeldin A enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D cultures.Advanced prostate cancer--a case for adjuvant differentiation therapy.The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.Dual silencing of Hsp27 and c-FLIP enhances doxazosin-induced apoptosis in PC-3 prostate cancer cells.Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer.
P2860
Q21090644-D38D807B-9A68-4407-BD3B-FBE27451E6FCQ34291736-DF213713-DF91-47FF-9565-38BBA547F557Q34416771-339675F4-F103-4919-AF32-E6B0C0D539FFQ35858905-AE4816C4-909A-43E6-8884-44C613DF61CBQ36029539-2FFAC0FA-95F5-4261-B706-1A58415BE431Q36211507-0BF5D1C2-7025-4D0B-B318-D6480A5C490AQ36789277-EA8EF1AC-352B-4593-99F9-36CCF70FB907Q37297350-D216AFDE-1B8A-4C9B-8C8A-825B8605259FQ37337217-90E9E56D-6715-4EC9-B5F8-BD4CB913553FQ37596358-4B0F27BF-EA7F-43F3-95E7-A45C045B5ECAQ37694029-9CCC9542-EC27-4CB0-AC65-A0E4CB2FFC51Q38183819-18B31ADF-421B-426C-947C-F83AAD06FFB0Q38947366-4755B2EA-A97B-4768-8A73-8E4F7C5F2AFCQ39265656-E72965CA-87C7-4EA1-878B-8E732FE4BEB6Q43083930-C6427651-39AE-4C5F-8793-DF9AE0E949FBQ46369078-A010401C-8ADE-42D3-A169-6D6704DBB279Q48313390-D0C965F6-4D83-4B1F-BF37-B43CFC3AFD50Q50893407-EE62D776-6ADF-4C7B-BDEA-C3264FDEC639Q50920040-B6D213E2-EFF4-4AE4-A955-3A26CA85F2CCQ50971441-73C1C265-4A59-4E1B-83B5-40FFFFA1D6C8Q51797974-1A101157-E60A-46D9-9CAC-6EAE997A09BFQ53701939-FBAA686E-25E4-419D-A84C-099CBF4C952B
P2860
Abiraterone in prostate cancer: a new angle to an old problem
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Abiraterone in prostate cancer: a new angle to an old problem
@ast
Abiraterone in prostate cancer: a new angle to an old problem
@en
Abiraterone in prostate cancer: a new angle to an old problem
@nl
type
label
Abiraterone in prostate cancer: a new angle to an old problem
@ast
Abiraterone in prostate cancer: a new angle to an old problem
@en
Abiraterone in prostate cancer: a new angle to an old problem
@nl
prefLabel
Abiraterone in prostate cancer: a new angle to an old problem
@ast
Abiraterone in prostate cancer: a new angle to an old problem
@en
Abiraterone in prostate cancer: a new angle to an old problem
@nl
P2093
P2860
P3181
P1476
Abiraterone in prostate cancer: a new angle to an old problem
@en
P2093
M. N. Stein
R. S. DiPaola
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-11-1805
P407
P577
2012-04-01T00:00:00Z